CN104628577B - The synthetic method of Bisolvon - Google Patents

The synthetic method of Bisolvon Download PDF

Info

Publication number
CN104628577B
CN104628577B CN201510034747.3A CN201510034747A CN104628577B CN 104628577 B CN104628577 B CN 104628577B CN 201510034747 A CN201510034747 A CN 201510034747A CN 104628577 B CN104628577 B CN 104628577B
Authority
CN
China
Prior art keywords
bisolvon
hydrogen chloride
method preparing
reaction
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510034747.3A
Other languages
Chinese (zh)
Other versions
CN104628577A (en
Inventor
郭相国
阮诗文
严恭超
徐丽萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Ding Ya pharmaceutical chemistry Science and Technology Ltd.
Original Assignee
Shanghai Moxue Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Moxue Pharmaceutical Co Ltd filed Critical Shanghai Moxue Pharmaceutical Co Ltd
Priority to CN201510034747.3A priority Critical patent/CN104628577B/en
Publication of CN104628577A publication Critical patent/CN104628577A/en
Application granted granted Critical
Publication of CN104628577B publication Critical patent/CN104628577B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to the preparation method of a kind of Bisolvon, the method is with 2 amino 3,5 dibromo benzaldehydes and N methyl cyclohexylamine are raw material, at catalyst and next step synthesis bromhexine free alkali of reducing agent existence condition, the bromhexine free alkali of generation and hydrogen chloride salt-forming reagent carry out salt-forming reaction and prepare Bisolvon;Wherein, sulfonic acid type catalyst Amberlyst 15 (H) selected by catalyst.The method significantly reducing reactions steps, shorten the production cycle, improve reaction yield, reduce production cost, the preparation method of the present invention is without using hypertoxicity reagent, and reaction condition is gentle, and to equipment without particular/special requirement, environmental pollution is little.

Description

The synthetic method of Bisolvon
Technical field
The invention belongs to chemical medicine synthesis field, a kind of method being specifically related to synthetic hydrochloric acid bromhexine.
Background technology
Bisolvon, chemical name is Bromhexine Hydrochloride, structure Formula is as follows:
The Novel mucous dissolubility expectorant agent of the structure synthesis of its effective ingredient proposed according to medicinal plants Adhatoda vasica Nees, There is the stronger effect dissolving glutinous expectorant, mucopolysaccharide Study On Fiber Differentiation and the cracking of apoplexy due to phlegm, the synthesis of suppression mucopolysaccharide can be made, make apoplexy due to phlegm Sialic acid content reduces, thus reduces the viscosity of expectorant, makes sputum be prone to expectoration.Clinically for acute/chronic bronchitis, asthma, Bronchiectasis, emophysematous treatment.
The preparation method of existing Bisolvon crude drug mainly has following several:
Method one (J. Label. Compd. Radiopharm 2005;48:429 434.): with 2-amino-3,5- Dibromobenzoic acid is raw material, through condensing agent dicyclohexylcarbodiimide (DCC), catalyst DMAP (DMAP) and work Agent N-hydroxy-succinamide (HOSu) activates, and is directly condensed prepares N-methyl-N-cyclohexyl-2-ammonia with N-methylcyclohexylamine Base-3,5-dibromobenzene Methanamide, then prepare bromhexine free alkali through lithium borohydride reduction.
Method two (CN102617359B, CN102531922B, CN102924295B): 2-nitro bromobenzyl and N-methyl cyclohexane Amine is initiation material, occurs aminating reaction to generate N-(2-nitrobenzyl)-N-methylcyclohexylamine, and this intermediate is under raney ni catalysis Anti-raw ortho position nitro hydrogenation reduction reaction generates N-(2-amino benzyl)-N-methylcyclohexylamine, then obtains bromhexine trip through bromine bromo From alkali, salt is become to obtain Bisolvon with hydrogen chloride.Or similar can also use hydrazine hydrate that nitro is reduced into amino, then with Bromine generation substitution reaction, becomes salt to obtain Bisolvon with hydrogen chloride.This synthesis technique severe reaction conditions, makes in building-up process With the reagent such as hydrazine hydrate, bromine, hydrazine hydrate toxicity is relatively big, and serious to personnel and environmental hazard, the use of simple substance bromine causes giving up Water difficult treatment.
Method three (CN104003887A): with 2-amino-3,5-dibromo benzaldehyde is raw material, and aldehyde radical reduction is obtained 2-ammonia Base-3,5-dibromobenzene methanol, then obtain 6 with double (trichloromethyl) carbonate reaction, 8-bis-bromo-1H-benzo [d] [1,3] oxazines- 2 (4H)-one, last and N-methylcyclohexylamine carries out open loop and prepares bromhexine free alkali.
Method four (CN102531922B): triacetic acid borate and 2-amino-3,5-dibromobenzene methanol reacts, and generates 2-ammonia Base-3,5-dibromobenzene methanol chelate, then react generation bromhexine free alkali, last and hcl reaction with N-methylcyclohexylamine Generate Bisolvon.
Method five (CN104003887A): with 2-amino-3,5-dibromobenzene methanol, as raw material, uses thionyl chloride to carry out Chloro, then carry out aminating reaction with N-methylcyclohexylamine and obtain bromhexine free alkali, hydrochloric acid becomes salt to obtain Bisolvon.Or Similar also can react with N-methylcyclohexylamine through p-methyl benzene sulfonic chloride catalysis under the conditions of-70 DEG C, becomes salt to prepare with hydrochloric acid Bisolvon.This route operating procedure is few, but initiation material 2-amino-3,5-dibromobenzene methanol prices is expensive, sets production Standby condition requires height.
In above-mentioned syntheti c route, there is initiation material or intermediate is not easy to obtain, intermediate is unstable, be difficult to monitor, reaction Condition is harsh, the problems such as environmental pollution is big.
Summary of the invention
The technical problem to be solved is to provide a kind of method preparing Bisolvon.The synthesis side of the present invention Method technique is simple, and reaction condition is gentle, and raw material is easy to get, and product yield is high, and environmental pollution is little.
For solve above-mentioned technical problem, the present invention by the following technical solutions:
Specifically, a kind of method preparing Bisolvon, the method comprises the steps:
(1) 2-amino-3,5 dibromo benzaldehyde and N-methylcyclohexylamine are carried out under catalyst and reducing agent existence condition Reductive amination process one-step synthesis bromhexine free alkali;
(2) bromhexine free alkali and hydrogen chloride salt-forming reagent carry out salt-forming reaction and prepare Bisolvon.
Wherein, the reducing agent in step (1) is sodium borohydride or potassium borohydride, preferably sodium borohydride.
Reaction dissolvent in step (1) is oxolane, Isosorbide-5-Nitrae-dioxane or isopropyl ether, preferably oxolane.
Catalyst in step (1) is solid acid catalyst, preferably Amberlyst 15 (H), Amberlyst 15 (H) being a kind of sulfonic acid type catalyst, No. CAS is 9037-24-5, buys in Chengdu bass spy reagent company limited.
In step (1), reaction temperature is 10 ~ 40 DEG C, preferably 25 ~ 30 DEG C.
In step (1), 2-amino-3, the molal weight of 5 dibromo benzaldehydes and N-methylcyclohexylamine than for 1:1.1 ~ 1.3, sodium borohydride and 2-amino-3, the molal weight ratio of 5 dibromo benzaldehydes is 2 ~ 3:1, the addition of catalyst and 2-amino- The mass ratio of 3,5 dibromo benzaldehydes is 80 ~ 90mg:1g.
In the salt-forming reaction of step (2), described hydrogen chloride salt-forming reagent be hydrogen chloride gas, the alcoholic solution of hydrogen chloride or The ethereal solution of hydrogen chloride;It is preferably the ethereal solution of hydrogen chloride;The more preferably 1,4-dioxane solution of hydrogen chloride.
Compared with prior art, the present invention, by changing synthetic route and reaction condition, uses raw material 2-cheap and easy to get Amino-3,5 dibromo benzaldehydes and N-methylcyclohexylamine are at catalyst and next step synthesis bromhexine of reducing agent existence condition, significantly Decrease reactions steps, shorten the production cycle;The Amberlyst 15 (H) using cheap environmental protection makees catalyst, shortens anti- Between Ying Shi, improve reaction yield;Catalyst Amberlyst 15 (H) recyclable recycling, reduces production cost simultaneously; The preparation method of the present invention is without using hypertoxicity reagent, and reaction condition is gentle, and to equipment without particular/special requirement, environmental pollution is little.
Detailed description of the invention
The 1,4-dioxane solution (content 4M) of hydrogen chloride is purchased from Shanghai Jing Chun biochemical technology limited company.
The preparation of embodiment 1 Bisolvon
(1) preparation of bromhexine free alkali
Take 2-amino-3,5 dibromo benzaldehyde and the N-methyl of 2.7g (0.0239mol) of 6.0 g (0.0215 mol) Cyclohexylamine, adds the oxolane of 100mL, and at 25 DEG C, stirring makes its mix homogeneously, is then sequentially added into 0.5g Amberlyst 15 (H), 1.7g sodium borohydride (0.0447mol), continue stirring, by TLC method, (HSGF254 silica gel plate launches Agent: VPetroleum ether:VEthyl acetate=9:1) monitoring reaction process, after reaction terminating, filters mixture, adds 30mL saturated in filtrate Saline solution, stratification, ether extraction (3 × 50mL), merge organic facies, washing, saturated common salt is washed, and anhydrous sodium sulfate is done Dry, filter, concentrate and remove solvent, column chromatography (petroleum ether: ethyl acetate=9:1) obtains pale yellow oily liquid body 4.7g, yield 58%。
(2) preparation of Bisolvon
In the round-bottomed flask of 100mL, add 4.7g bromhexine, under condition of ice bath, add the Isosorbide-5-Nitrae-two of 20mL hydrogen chloride Oxygen six ring solution (4M), continues stirring 30 ~ 60min, filters after adding, filter cake ethyl acetate is washed, and obtains Bisolvon Crude product 4.8g, then with 20mL dehydrated alcohol recrystallization, obtain Bisolvon 4.3g, with raw material 2-amino-3,5-dibromobenzene The productivity that formaldehyde calculates is 48%, fusing point 235-237 DEG C.
1H-NMR (CD3OD, 400MHz): δ 1.13-2.14 (m, 10H), 2.66 (s, 3H), 3.29-3.32 (m, 1H), 4.16-4.17 (m, 1H), 4.45-4.46 (m, 1H), 7.41-7.43 (m, 1H), 7.65-7.67 (m, 1H). through with standard substance comparison after, determine that the product obtained is Bisolvon.

Claims (11)

1. the method preparing Bisolvon, it is characterised in that the method comprises the steps:
(1) 2-amino-3,5 dibromo benzaldehyde and N-methylcyclohexylamine carry out reduction amine under catalyst and reducing agent existence condition Change reaction one-step synthesis bromhexine free alkali;
(2) bromhexine free alkali and hydrogen chloride salt-forming reagent carry out salt-forming reaction and prepare Bisolvon;
Wherein, the catalyst described in step (1) is Amberlyst 15 (H).
The method preparing Bisolvon the most as claimed in claim 1, it is characterised in that the reducing agent described in step (1) For sodium borohydride or potassium borohydride.
The method preparing Bisolvon the most as claimed in claim 2, it is characterised in that reducing agent is sodium borohydride.
The method preparing Bisolvon the most as claimed in claim 1, it is characterised in that the reaction dissolvent in step (1) is Oxolane, 1,4-dioxane or isopropyl ether.
The method preparing Bisolvon the most as claimed in claim 4, it is characterised in that the reaction dissolvent in step (1) is Oxolane.
The method preparing Bisolvon the most as claimed in claim 1, it is characterised in that in step (1) reaction temperature be 10 ~ 40℃。
The method preparing Bisolvon the most as claimed in claim 6, it is characterised in that in step (1) reaction temperature be 25 ~ 30℃。
The method preparing Bisolvon the most as claimed in claim 1, it is characterised in that 2-amino-3,5 dibromo benzaldehydes and The amount of the material of N-methylcyclohexylamine ratio for 1:1.1 ~ 1.3, sodium borohydride and 2-amino-3, the amount of the material of 5 dibromo benzaldehydes Ratio is 2 ~ 3:1, the addition of catalyst and 2-amino-3, and the mass ratio of 5 dibromo benzaldehydes is 80 ~ 90mg:1g.
The method preparing Bisolvon the most as claimed in claim 1, it is characterised in that the hydrogen chloride described in step (2) Salt-forming reagent is hydrogen chloride gas, the alcoholic solution of hydrogen chloride or the ethereal solution of hydrogen chloride.
The method preparing Bisolvon the most as claimed in claim 9, it is characterised in that the hydrogen chloride described in step (2) Salt-forming reagent is the ethereal solution of hydrogen chloride.
11. methods preparing Bisolvon as claimed in claim 10, it is characterised in that the ethereal solution of described hydrogen chloride 1,4-dioxane solution for hydrogen chloride.
CN201510034747.3A 2015-01-24 2015-01-24 The synthetic method of Bisolvon Active CN104628577B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510034747.3A CN104628577B (en) 2015-01-24 2015-01-24 The synthetic method of Bisolvon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510034747.3A CN104628577B (en) 2015-01-24 2015-01-24 The synthetic method of Bisolvon

Publications (2)

Publication Number Publication Date
CN104628577A CN104628577A (en) 2015-05-20
CN104628577B true CN104628577B (en) 2016-12-07

Family

ID=53207873

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510034747.3A Active CN104628577B (en) 2015-01-24 2015-01-24 The synthetic method of Bisolvon

Country Status (1)

Country Link
CN (1) CN104628577B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105461659A (en) * 2014-09-28 2016-04-06 韶远科技(上海)有限公司 Amplifiable synthetic method of aminobenzylamine compounds
CN106631828A (en) * 2016-12-14 2017-05-10 成都新恒创药业有限公司 Preparation method of bromhexine hydrochloride
CN109535010B (en) * 2018-12-27 2021-10-26 广州一品红制药有限公司 Preparation method of bromhexine hydrochloride
CN112194585B (en) * 2020-10-29 2022-09-09 济南久隆医药科技有限公司 Synthetic method of bromhexine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103333074B (en) * 2013-07-02 2015-05-20 万邦德制药集团股份有限公司 Production method of bromhexine hydrochloride

Also Published As

Publication number Publication date
CN104628577A (en) 2015-05-20

Similar Documents

Publication Publication Date Title
CN104628577B (en) The synthetic method of Bisolvon
CN105820110B (en) Mo Fanselin synthetic methods
CN102659726B (en) Method for synthesis of dronedarone
CN103497226B (en) Refinement method of methylamino abamectin benzoate
CN100404497C (en) Nitrile reducing process to prepare amine
CN102010400B (en) S-5-substituted-N-2'-(thiofuran-2-yl-) ethyl-1,2,3,4-tetranap-2-amine or chiral hydrochloric acid and application thereof to preparation of rotigotine
CN102964268A (en) Synthesis method of menthyl amide cooling agent
CN101654419A (en) Preparation method of fluvoxamine maleate
CN112047883A (en) Preparation method of cisatracurium besylate
CN103896795B (en) The preparation method and its usage of benzamide compound, its intermediate
CN102199098B (en) New synthesis method and application of (R)-N-benzyl-1-(4-methoxyphenyl)-2-propylamine
CN108164423B (en) Preparation method of naftifine hydrochloride
CN104447355A (en) Novel method for preparing bromhexine hydrochloride
CN102050748B (en) Method for preparing expectorant, namely ambroxol key intermediate trans-4-[(2-amino benzyl) amino]-cyclohexanol
CN111777520B (en) Synthesis method of multi-substituted dimethylamino phenyl acetic acid compound
CN101514163B (en) Optically pure Sibutramine and process for preparing salt derivative thereof
CN103242289B (en) Preparation method of N,N-diallyl-(1R,2R)-2-aminomethyl-1-(2-thienyl)cyclopropanecarboxamide hydrochloride
CN102164886A (en) Process for the preparation of O-desmethylvenlafaxine
CN112920053A (en) Preparation method of chiral alpha-methyl aromatic ethylamine
CN110790690A (en) Synthetic method of 3, 4-difluoro-2- ((phenylthio) methyl) benzoic acid
CN101407469A (en) Preparation method of bupropion hydrochloride
CN109942516A (en) Compound R A is preparing the purposes in Bu Waxitan intermediate chirality butyrolactone
CN104003887A (en) Preparation method of bromhexine hydrochloride
CN104119238B (en) A kind of preparation method of 4-(a chlorine difluoro-methoxy) aniline
CN102993116A (en) Preparation method of benzoxazine excitant

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20181114

Address after: 201203 room 304, Harley Road, Zhangjiang hi tech park, Pudong New Area, Shanghai, 1043

Patentee after: Shanghai Ding Ya pharmaceutical chemistry Science and Technology Ltd.

Address before: 201203 Room 301, Harley Road, Zhangjiang hi tech park, Pudong New Area, Shanghai, 1043

Patentee before: SHANGHAI MOXUE PHARMACEUTICAL CO., LTD.

TR01 Transfer of patent right